{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:55:46Z","timestamp":1791320146060,"version":"4.3.1"},"reference-count":137,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U01 HD087198"],"award-info":[{"award-number":["U01 HD087198"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01 HD088386"],"award-info":[{"award-number":["R01 HD088386"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The road to low-dose aspirin therapy for the prevention of preeclampsia began in the 1980s with the discovery that there was increased thromboxane and decreased prostacyclin production in placentas of preeclamptic women. At the time, low-dose aspirin therapy was being used to prevent recurrent myocardial infarction and other thrombotic events based on its ability to selectively inhibit thromboxane synthesis without affecting prostacyclin synthesis. With the discovery that thromboxane was increased in preeclamptic women, it was reasonable to evaluate whether low-dose aspirin would be effective for preeclampsia prevention. The first clinical trials were very promising, but then two large multi-center trials dampened enthusiasm until meta-analysis studies showed aspirin was effective, but with caveats. Low-dose aspirin was most effective when started &lt;16 weeks of gestation and at doses &gt;100 mg\/day. It was effective in reducing preterm preeclampsia, but not term preeclampsia, and patient compliance and patient weight were important variables. Despite the effectiveness of low-dose aspirin therapy in correcting the placental imbalance between thromboxane and prostacyclin and reducing oxidative stress, some aspirin-treated women still develop preeclampsia. Alterations in placental sphingolipids and hydroxyeicosatetraenoic acids not affected by aspirin, but with biologic actions that could cause preeclampsia, may explain treatment failures. Consideration should be given to aspirin\u2019s effect on neutrophils and pregnancy-specific expression of protease-activated receptor 1, as well as additional mechanisms of action to prevent preeclampsia.<\/jats:p>","DOI":"10.3390\/ijms22136985","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T04:31:07Z","timestamp":1624941067000},"page":"6985","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["The Road to Low-Dose Aspirin Therapy for the Prevention of Preeclampsia Began with the Placenta"],"prefix":"10.3390","volume":"22","author":[{"given":"Scott W.","family":"Walsh","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6199-0480","authenticated-orcid":false,"suffix":"III","given":"Jerome F.","family":"Strauss","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0090-6980(76)90048-4","article-title":"A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation","volume":"12","author":"Moncada","year":"1976","journal-title":"Prostaglandins"},{"key":"ref_2","first-page":"293","article-title":"Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin","volume":"30","author":"Moncada","year":"1979","journal-title":"Pharmacol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/oxfordjournals.bmb.a071832","article-title":"The prostacyclin--thromboxane A2 balance: Pathophysiological and therapeutic implications","volume":"39","author":"Bunting","year":"1983","journal-title":"Br. Med. Bull."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1056\/NEJM198308183090703","article-title":"Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study","volume":"309","author":"Lewis","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJM198312153092410","article-title":"Aspirin as an Antithrombotic Medication","volume":"309","author":"Marcus","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJM198207083070209","article-title":"Aspirin to Prevent Arterial Thrombosis","volume":"307","author":"Salzman","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(80)92746-4","article-title":"Maternal vascular prostacyclin activity in pre-eclampsia","volume":"316","author":"Bussolino","year":"1980","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S0140-6736(80)92443-5","article-title":"Reduced prostacyclin production in pre-eclampsia","volume":"316","author":"Downing","year":"1980","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0090-6980(80)90010-6","article-title":"Reduced umbilical and placental vascular prostacyclin in severe preeclampsia","volume":"20","author":"Remuzzi","year":"1980","journal-title":"Prostaglandins"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0002-9378(85)80223-4","article-title":"Preeclampsia: An imbalance in placental prostacyclin and thromboxane production","volume":"152","author":"Walsh","year":"1985","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1365-2362.1996.87238.x","article-title":"Altered release of endothelin-1,2 and thromboxane B2 from trophoblastic cells in pre-eclampsia","volume":"26","author":"Cervar","year":"1996","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0143-4004(96)90022-3","article-title":"In-vitro secretion of prostanoids by placental villous cytotrophoblasts in pre-eclampsia","volume":"17","author":"Ding","year":"1996","journal-title":"Placenta"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/10641959609015693","article-title":"Placental Production of Lipid Peroxides, Thromboxane, and Prostacyclin in Preeclampsia","volume":"15","author":"Walsh","year":"1996","journal-title":"Hypertens. Pregnancy"},{"key":"ref_14","first-page":"1225","article-title":"Eicosanoid biosynthetic enzymes in placental and decidual tissues from preeclamptic pregnancies: Increased expression of thromboxane-A2 synthase gene","volume":"78","author":"Woodworth","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.placenta.2004.07.007","article-title":"Increased phospholipase A2 and thromboxane but not prostacyclin production by placental trophoblast cells from normal and preeclamptic pregnancies cultured under hypoxia condition","volume":"26","author":"Bowen","year":"2005","journal-title":"Placenta"},{"key":"ref_16","first-page":"3059","article-title":"The Expression and Activity of Prostaglandin H Synthase-2 Is Enhanced in Trophoblast from Women with Preeclampsia","volume":"82","author":"Johnson","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0140-6736(86)91891-X","article-title":"Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae","volume":"327","author":"Wallenburg","year":"1986","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(94)92633-6","article-title":"CLASP: A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group","volume":"343","author":"Beroyz","year":"1994","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJM199310213291701","article-title":"Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"329","author":"Sibai","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ajog.2017.12.238","article-title":"Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage","volume":"218","author":"Roberge","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0090-6980(89)90001-4","article-title":"Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol)","volume":"37","author":"Drvota","year":"1989","journal-title":"Prostaglandins"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/0002-9378(93)90362-M","article-title":"The effect of acetaminophen on prostacyclin production in pregnant women","volume":"168","author":"Krammer","year":"1993","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"685.e1","DOI":"10.1016\/j.ajog.2017.08.110","article-title":"Aspirin for Evidence-Based Preeclampsia Prevention trial: Influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia","volume":"217","author":"Wright","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"86A","DOI":"10.1016\/1071-5576(96)82503-2","article-title":"Prevention of preeclampsia with low-dose aspirin in nulliparas: A compliance analysis [Abstract #56]","volume":"3","author":"Hauth","year":"1996","journal-title":"J. Soc. Gynecol. Investig."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.plefa.2003.04.010","article-title":"Eicosanoids in preeclampsia","volume":"70","author":"Walsh","year":"2004","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: A meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: A meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet. Gynecol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000336662","article-title":"Early Administration of Low-Dose Aspirin for the Prevention of Preterm and Term Preeclampsia: A Systematic Review and Meta-Analysis","volume":"31","author":"Roberge","year":"2012","journal-title":"Fetal Diagn. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: Systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ajog.2018.03.018","article-title":"Optimal aspirin dosing for preeclampsia prevention","volume":"219","author":"Seidler","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"580.e1","DOI":"10.1016\/j.ajog.2019.02.034","article-title":"Aspirin delays the development of preeclampsia","volume":"220","author":"Wright","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"385.e1","DOI":"10.1016\/j.ajog.2019.01.222","article-title":"Obesity and laboratory aspirin resistance in high-risk pregnant women treated with low-dose aspirin","volume":"220","author":"Finneran","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_34","unstructured":"American College of Obstetricians and Gynecologists (2013). Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy. Obstet. Gynecol., 122, 1122\u20131131."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists (2018). ACOG Committee Opinion No. 743: Low-Dose Aspirin Use during Pregnancy. Obstet. Gynecol., 132, e44\u2013e52.","DOI":"10.1097\/AOG.0000000000002708"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"695","DOI":"10.7326\/M13-2844","article-title":"Low-Dose Aspirin for Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force","volume":"160","author":"Henderson","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"d2901","DOI":"10.1136\/bmj.d2901","article-title":"Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: Randomised controlled trial","volume":"342","author":"Espino","year":"2011","journal-title":"BMJ"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Monari, F., Menichini, D., Pignatti, L., Basile, L., Facchinetti, F., and Neri, I. (2021). Effect of L-Arginine supplementation in pregnant women with chronic hypertension and previous placenta vascular disorders receiving Aspirin prophylaxis: A randomized control trial. Minerva Obstet. Gynecol.","DOI":"10.23736\/S2724-606X.21.04827-2"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1007\/s43032-020-00234-2","article-title":"Placental Production of Eicosanoids and Sphingolipids in Women Who Developed Preeclampsia on Low-Dose Aspirin","volume":"27","author":"Walsh","year":"2020","journal-title":"Reprod. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1210\/jcem-68-3-676","article-title":"Thromboxane and Prostacyclin Production by Different Compartments of the Human Placental Villus","volume":"68","author":"Nelson","year":"1989","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/0002-9378(88)90560-1","article-title":"Low-dose aspirin inhibits thromboxane, but not prostacyclin, production by human placental arteries","volume":"159","author":"Thorp","year":"1988","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_42","first-page":"1888","article-title":"Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia","volume":"80","author":"Walsh","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/10641959809006076","article-title":"Maternal Perfusion with Low-Dose Aspirin Preferentially Inhibits Placental Thromboxane While Sparing Prostacyclin","volume":"17","author":"Walsh","year":"1998","journal-title":"Hypertens. Pregnancy"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/0002-9378(89)90932-0","article-title":"Aspirin differentially affects thromboxane and prostacyclin production by trophoblast and villous core compartments of human placental villi","volume":"161","author":"Nelson","year":"1989","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0891-5849(94)00157-F","article-title":"Aspirin inhibits both lipid peroxides and thromboxane in preeclamptic placentas","volume":"18","author":"Wang","year":"1995","journal-title":"Free Radic. Biol. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1096\/fasebj.14.10.1289","article-title":"Placental isoprostane is significantly increased in preeclampsia","volume":"14","author":"Walsh","year":"2000","journal-title":"FASEB J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.placenta.2013.11.013","article-title":"Review: Maternal and placental antioxidant response to preeclampsia\u2014Impact on vasoactive eicosanoids","volume":"35","author":"Bilodeau","year":"2014","journal-title":"Placenta"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-2952(95)02072-1","article-title":"The isoprostanes. Current knowledge and directions for future research","volume":"51","author":"Morrow","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"ref_49","unstructured":"Samuelsson, B., Ramwell, P.W., Paoletti, R., Folco, G., Granstrom, E., and Nicosia, S. (1995). The isoprostanes: Novel markers of lipid peroxidation and potential mediators of oxidant injury. Advances in Prostaglandin, Thromboxane, and Leukotriene Research, Raven Press."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"9383","DOI":"10.1073\/pnas.87.23.9383","article-title":"A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism","volume":"87","author":"Morrow","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/s-2007-1016256","article-title":"Maternal-Placental Interactions of Oxidative Stress and Antioxidants in Preeclampsia","volume":"16","author":"Walsh","year":"1998","journal-title":"Semin. Reprod. Endocrinol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/01.RES.59.6.612","article-title":"PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH","volume":"59","author":"Kukreja","year":"1986","journal-title":"Circ. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0002-9378(12)80013-5","article-title":"Low-dose aspirin inhibits lipid peroxides and thromboxane but not prostacyclin in pregnant women","volume":"167","author":"Walsh","year":"1992","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.bbalip.2014.10.008","article-title":"Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid","volume":"1851","author":"Powell","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/ATVBAHA.113.301335","article-title":"15-Lipoxygenase Promotes Chronic Hypoxia\u2013Induced Pulmonary Artery Inflammation via Positive Interaction With Nuclear Factor-\u03baB","volume":"33","author":"Li","year":"2013","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_56","first-page":"175","article-title":"Leukotrienes","volume":"30","author":"Stenson","year":"1984","journal-title":"Adv. Intern. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.prostaglandins.2007.01.005","article-title":"Pharmacotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoids","volume":"83","author":"Rubin","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_58","first-page":"273","article-title":"Mediation of leukocyte components of inflammatory reactions by lipoxygenase products of arachidonic acid","volume":"9","author":"Goetzl","year":"1982","journal-title":"Adv. Prostaglandin Thromboxane Leukot. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.prostaglandins.2015.03.002","article-title":"Vascular actions of 20-HETE","volume":"120","author":"Hoopes","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.prostaglandins.2016.05.007","article-title":"The role of 20-HETE in cardiovascular diseases and its risk factors","volume":"125","author":"Waldman","year":"2016","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_61","first-page":"74","article-title":"Recent developments on the vascular effects of 20-hydroxyeicosatetraenoic acid","volume":"26","author":"Garcia","year":"2017","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/0002-9378(95)91333-5","article-title":"Placental pathologic features of preterm preeclampsia","volume":"173","author":"Salafia","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/jcp.27353","article-title":"The role of sphingosine 1 phosphate in coronary artery disease and ischemia reperfusion injury","volume":"234","author":"Mihanfar","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbalip.2008.06.002","article-title":"Ceramidases: Regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate","volume":"1781","author":"Mao","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1083\/jcb.114.1.155","article-title":"Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation","volume":"114","author":"Zhang","year":"1991","journal-title":"J. Cell Biol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Norris, G.H., and Blesso, C.N. (2017). Dietary and Endogenous Sphingolipid Metabolism in Chronic Inflammation. Nutrients, 9.","DOI":"10.3390\/nu9111180"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jbior.2016.10.002","article-title":"Ceramidases, roles in sphingolipid metabolism and in health and disease","volume":"63","author":"Coant","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.placenta.2013.12.006","article-title":"Review: Novel insights into the regulation of vascular tone by sphingosine 1-phosphate","volume":"35","author":"Kerage","year":"2014","journal-title":"Placenta"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ajog.2005.07.039","article-title":"Apoptosis and its role in the trophoblast","volume":"195","author":"Huppertz","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2017.09.009","article-title":"Vitamin D attenuates sphingosine-1-phosphate (S1P)-mediated inhibition of extravillous trophoblast migration","volume":"60","author":"Westwood","year":"2017","journal-title":"Placenta"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Charkiewicz, K., Goscik, J., Blachnio-Zabielska, A., Raba, G., Sakowicz, A., Kalinka, J., Chabowski, A., and Laudanski, P. (2017). Sphingolipids as a new factor in the pathomechanism of preeclampsia\u2014Mass spectrometry analysis. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0177601"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/15548627.2015.1034414","article-title":"Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia","volume":"11","author":"Ermini","year":"2015","journal-title":"Autophagy"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0015-0282(02)02976-X","article-title":"Cytokine production in natural killer cells and lymphocytes in pregnant women compared with women in the follicular phase of the ovarian cycle","volume":"77","author":"Bouman","year":"2002","journal-title":"Fertil. Steril."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000009973","article-title":"Comparison of the Differential Distribution of Leukocytes in Preeclampsia versus Uncomplicated Pregnancy","volume":"45","author":"Lurie","year":"1998","journal-title":"Gynecol. Obstet. Investig."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199802123380706","article-title":"Chemokines\u2014Chemotactic Cytokines That Mediate Inflammation","volume":"338","author":"Luster","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/01.HYP.0000130483.83154.37","article-title":"Neutrophils Infiltrate Resistance-Sized Vessels of Subcutaneous Fat in Women with Preeclampsia","volume":"44","author":"Leik","year":"2004","journal-title":"Hypertension"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/10641950801958067","article-title":"Neutrophils, but Not Lymphocytes or Monocytes, Infiltrate Maternal Systemic Vasculature in Women with Preeclampsia","volume":"27","author":"Cadden","year":"2008","journal-title":"Hypertens. Pregnancy"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/HYPERTENSIONAHA.111.176602","article-title":"Mechanisms of Enhanced Vascular Reactivity in Preeclampsia","volume":"58","author":"Mishra","year":"2011","journal-title":"Hypertension"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"48.e1","DOI":"10.1016\/j.ajog.2006.08.038","article-title":"Activation of NF-kappaB and expression of COX-2 in association with neutrophil infiltration in systemic vascular tissue of women with preeclampsia","volume":"196","author":"Shah","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1067\/mob.2001.117311","article-title":"Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia","volume":"185","author":"Gervasi","year":"2001","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0002-9378(98)70254-6","article-title":"Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis","volume":"179","author":"Sacks","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/HYPERTENSIONAHA.111.188730","article-title":"Reduced Methylation of the Thromboxane Synthase Gene Is Correlated with Its Increased Vascular Expression in Preeclampsia","volume":"59","author":"Mousa","year":"2012","journal-title":"Hypertension"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/1933719114557899","article-title":"Neutrophil Release of Myeloperoxidase in Systemic Vasculature of Obese Women May Put Them at Risk for Preeclampsia","volume":"22","author":"Shukla","year":"2015","journal-title":"Reprod. Sci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.2174\/1381612033453884","article-title":"Development of Proteinase-Activated Receptor 1 Antagonists as Therapeutic Agents for Thrombosis, Restenosis and Inflammatory Diseases","volume":"9","author":"Ahn","year":"2003","journal-title":"Curr. Pharm. Des."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.cell.2009.02.018","article-title":"Platelet Matrix Metalloprotease-1 Mediates Thrombogenesis by Activating PAR1 at a Cryptic Ligand Site","volume":"137","author":"Trivedi","year":"2009","journal-title":"Cell"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1165\/rcmb.2005-0109OC","article-title":"Proteinase-Activated Receptor-1 Mediates Elastase-Induced Apoptosis of Human Lung Epithelial Cells","volume":"33","author":"Suzuki","year":"2005","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1210\/jcem.87.8.8727","article-title":"Expression of thrombin receptors in endothelial cells and neutrophils from normal and preeclamptic pregnancies","volume":"87","author":"Wang","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1189\/jlb.0108001","article-title":"Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity","volume":"83","author":"Shpacovitch","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ajpath.2010.11.003","article-title":"Increased Expression of Matrix Metalloproteinase-1 in Systemic Vessels of Preeclamptic Women: A Critical Mediator of Vascular Dysfunction","volume":"178","author":"Cappello","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1007\/s43032-020-00232-4","article-title":"Proteases Activate Pregnancy Neutrophils by a Protease-Activated Receptor 1 Pathway: Epigenetic Implications for Preeclampsia","volume":"27","author":"Walsh","year":"2020","journal-title":"Reprod. Sci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1126\/science.1210944","article-title":"Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA","volume":"333","author":"He","year":"2011","journal-title":"Science"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1126\/science.1210597","article-title":"Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine","volume":"333","author":"Ito","year":"2011","journal-title":"Science"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1170116","article-title":"Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1","volume":"324","author":"Tahiliani","year":"2009","journal-title":"Science"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"10396","DOI":"10.1021\/ja4028346","article-title":"Ascorbic Acid Enhances Tet-Mediated 5-Methylcytosine Oxidation and Promotes DNA Demethylation in Mammals","volume":"135","author":"Yin","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1126\/science.1211917","article-title":"Molecular biology. Demystifying DNA demethylation","volume":"333","author":"Nabel","year":"2011","journal-title":"Science"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/gb-2013-14-5-r46","article-title":"5-Hydroxymethylcytosine is an essential intermediate of active DNA demethylation processes in primary human monocytes","volume":"14","author":"Klug","year":"2013","journal-title":"Genome Biol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1101\/gad.179184.111","article-title":"Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation","volume":"25","author":"Wu","year":"2011","journal-title":"Genes Dev."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/gb-2010-11-6-r63","article-title":"Active DNA demethylation in human postmitotic cells correlates with activating histone modifications, but not transcription levels","volume":"11","author":"Klug","year":"2010","journal-title":"Genome Biol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1159\/000373979","article-title":"Activation of PAR-1\/NADPH Oxidase\/ROS Signaling Pathways is Crucial for the Thrombin-Induced sFlt-1 Production in Extravillous Trophoblasts: Possible Involvement in the Pathogenesis of Preeclampsia","volume":"35","author":"Huang","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.fertnstert.2012.06.038","article-title":"Thrombin enhances soluble Fms-like tyrosine kinase 1 expression in trophoblasts; possible involvement in the pathogenesis of preeclampsia","volume":"98","author":"Zhao","year":"2012","journal-title":"Fertil. Steril."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/14767050802034859","article-title":"Over-expression of the thrombin receptor (PAR-1) in the placenta in preeclampsia: A mechanism for the intersection of coagulation and inflammation","volume":"21","author":"Erez","year":"2008","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/path.1338","article-title":"The pattern of expression of protease-activated receptors (PARs) during early trophoblast development","volume":"200","author":"Pruss","year":"2003","journal-title":"J. Pathol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.2353\/ajpath.2007.060465","article-title":"Thrombin Regulates Soluble fms-Like Tyrosine Kinase-1 (sFlt-1) Expression in First Trimester Decidua: Implications for Preeclampsia","volume":"170","author":"Lockwood","year":"2007","journal-title":"Am. J. Pathol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jsgi.2006.06.001","article-title":"Systemic Activation and Vascular Infiltration of Neutrophils With Term Labor","volume":"13","author":"Leik","year":"2006","journal-title":"J. Soc. Gynecol. Investig."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/1933719115607998","article-title":"Matrix Metalloproteinase 1 Causes Vasoconstriction and Enhances Vessel Reactivity to Angiotensin II via Protease-Activated Receptor 1","volume":"23","author":"Nugent","year":"2016","journal-title":"Reprod. Sci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1161\/01.ATV.17.12.3519","article-title":"Thrombin-induced thromboxane synthesis by human platelets. Properties of anion binding exosite I-independent receptor","volume":"17","author":"Henriksen","year":"1997","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1182\/blood-2012-09-355958","article-title":"Matrix metalloproteases and PAR1 activation","volume":"121","author":"Austin","year":"2013","journal-title":"Blood"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/35025229","article-title":"Thrombin signalling and protease-activated receptors","volume":"407","author":"Coughlin","year":"2000","journal-title":"Nature"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/j.1538-7836.2005.01377.x","article-title":"Protease-activated receptors in hemostasis, thrombosis and vascular biology","volume":"3","author":"Coughlin","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/01.RES.0000033520.95242.A2","article-title":"Galpha(q) and Gbetagamma regulate PAR-1 signaling of thrombin-induced NF-kappaB activation and ICAM-1 transcription in endothelial cells","volume":"91","author":"Rahman","year":"2002","journal-title":"Circ. Res."},{"key":"ref_111","first-page":"245","article-title":"Proteinase-activated receptors","volume":"53","author":"Macfarlane","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"7766","DOI":"10.1158\/0008-5472.CAN-05-3897","article-title":"Tumor-Derived Matrix Metalloproteinase-1 Targets Endothelial Proteinase-Activated Receptor 1 Promoting Endothelial Cell Activation","volume":"66","author":"Goerge","year":"2006","journal-title":"Cancer Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1042\/cs0920037","article-title":"Neutrophil CD11B Expression and Neutrophil Activation in Pre-Eclampsia","volume":"92","author":"Barden","year":"1997","journal-title":"Clin. Sci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1471-0528.1989.tb03358.x","article-title":"Neutrophil activation in pregnancy-induced hypertension","volume":"96","author":"Greer","year":"1989","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_115","first-page":"536","article-title":"The superoxide generation of neutrophils in normal and preeclamptic pregnancies","volume":"81","author":"Tsukimori","year":"1993","journal-title":"Obstet. Gynecol."},{"key":"ref_116","first-page":"227","article-title":"Activation of human blood monocytes by oxidized polyunsaturated fatty acids: A possible mechanism for the generation of lipid peroxides in the circulation","volume":"72","year":"1991","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ajog.2005.01.057","article-title":"Neutrophils from pregnant women produce thromboxane and tumor necrosis factor-\u03b1 in response to linoleic acid and oxidative stress","volume":"193","author":"Vaughan","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.ajog.2006.02.053","article-title":"Thromboxane mediates neutrophil superoxide production in pregnancy","volume":"195","author":"Vaughan","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/0002-9378(93)90419-J","article-title":"Secretion of lipid peroxides by the human placenta","volume":"169","author":"Walsh","year":"1993","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/hy0102.100778","article-title":"Activation of leukocytes during the uteroplacental passage in preeclampsia","volume":"39","author":"Mellembakken","year":"2002","journal-title":"Hypertension"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10641959409084168","article-title":"Lipid Peroxidation in Pregnancy","volume":"13","author":"Walsh","year":"1994","journal-title":"Hypertens. Pregnancy"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/1933719110361960","article-title":"Neutrophil Expression of Cyclooxygenase 2 in Preeclampsia","volume":"17","author":"Bachawaty","year":"2010","journal-title":"Reprod. Sci."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(76)93026-9","article-title":"Perinatal mortality and birth-weight in relation to aspirin taken during pregnancy","volume":"307","author":"Shapiro","year":"1976","journal-title":"Lancet"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/01.AOG.0000249609.04831.7c","article-title":"Mapping the theories of preeclampsia and the role of angiogenic factors: A systematic review","volume":"109","author":"Widmer","year":"2007","journal-title":"Obstet. Gynecol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"18928","DOI":"10.1002\/jcp.28533","article-title":"Low-dose aspirin reduces hypoxia-induced sFlt1 release via the JNK\/AP-1 pathway in human trophoblast and endothelial cells","volume":"234","author":"Lin","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1097\/HJH.0000000000002185","article-title":"Aspirin enhances trophoblast invasion and represses soluble fms-like tyrosine kinase 1 production: A putative mechanism for preventing preeclampsia","volume":"37","author":"Su","year":"2019","journal-title":"J. Hypertens."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41420-019-0170-x","article-title":"Low-dose aspirin protective effects are correlated with deregulation of HNF factor expression in the preeclamptic placentas from mice and humans","volume":"5","author":"Ducat","year":"2019","journal-title":"Cell Death Discov."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.preghy.2019.12.011","article-title":"Aspirin modulates STOX1 expression and reverses STOX1-induced insufficient proliferation and migration of trophoblast cells","volume":"19","author":"He","year":"2020","journal-title":"Pregnancy Hypertens."},{"key":"ref_130","first-page":"3361","article-title":"Phosphoproteomics reveals the apoptotic regulation of aspirin in the placenta of preeclampsia-like mice","volume":"12","author":"Huai","year":"2020","journal-title":"Am. J. Transl. Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"111591","DOI":"10.1016\/j.biopha.2021.111591","article-title":"Aspirin facilitates trophoblast invasion and epithelial-mesenchymal transition by regulating the miR-200-ZEB1 axis in preeclampsia","volume":"139","author":"Su","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-61779-289-2_13","article-title":"Isolation of Exosomes for Subsequent mRNA, MicroRNA, and Protein Profiling","volume":"784","author":"Rani","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/molehr\/gas013","article-title":"The expression profile of C19MC microRNAs in primary human trophoblast cells and exosomes","volume":"18","author":"Donker","year":"2012","journal-title":"Mol. Hum. Reprod."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1387\/ijdb.130349ys","article-title":"The role of trophoblastic microRNAs in placental viral infection","volume":"58","author":"Mouillet","year":"2014","journal-title":"Int. J. Dev. Biol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.placenta.2013.11.002","article-title":"Review: Placenta-specific microRNAs in exosomes\u2014Good things come in nano-packages","volume":"35","author":"Ouyang","year":"2014","journal-title":"Placenta"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"a023028","DOI":"10.1101\/cshperspect.a023028","article-title":"Placental Extracellular Vesicles and Feto-Maternal Communication","volume":"5","author":"Tong","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Dutta, S., Kumar, S., Hyett, J., and Salomon, C. (2019). Molecular Targets of Aspirin and Prevention of Preeclampsia and Their Potential Association with Circulating Extracellular Vesicles during Pregnancy. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184370"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/13\/6985\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:26:29Z","timestamp":1760163989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/13\/6985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":137,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["ijms22136985"],"URL":"https:\/\/doi.org\/10.3390\/ijms22136985","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,29]]}}}